Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Liraglutide

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Intensified Treatment with Basal Insulin Improves Control and Weight Loss Posted: Saturday, September 24, 2011

Adding insulin detemir to a treatment regimen of metformin and liraglutide improved glycemic control and led to sustained weight loss for up to 52 weeks in patients with type 2 diabetes.

Novo Nordisk receives US approval for Victoza® Posted: Tuesday, January 26, 2010

Novo Nordisk receives US approval for Victoza® (liraglutide) for the treatment of type 2 diabetes.

New Once-daily Treatment for Type 2 Diabetes Posted: Wednesday, July 15, 2009

A new treatment for Type 2 diabetes may soon be a reality in the U.S.. Liraglutide (Victoza), a once-daily injectable treatment for Type 2 diabetes, is pharmaceutical company Novo Nordisk's latest brain child and has been approved by the E.U.

Liraglutide Reverses Prediabetes 90% Posted: Wednesday, June 17, 2009

Researchers at the ADA reported that Liraglutide reverses prediabetes indices in most obese patients with existing prediabetes.

GLP-1 Liraglutide Versus Sulfonylureas Posted: Wednesday, June 17, 2009

Novo Nordisk experimental diabetes drug liraglutide was significantly better at helping patients control blood sugar than an older common medicine after two years of treatment, according to data from a clinical trial.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.